Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Masitinib versus placebo in severe COPD
2010-021495-29Phase 2Withdrawn
- Sponsor
- AB Science
- Start
- Sep 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in chronic obstructive pulmonary disease (COPD) comparing Masitinib with Placebo (2 arms). Primary endpoints: Absolute change from randomization in 6-minute walking distance and 6-minute walking distance test performance. Planned start Sep 2010; status: withdrawn.
02
Drugs
masitinib
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on 2010-021495-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-021495-29.